NCT01586000 - A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women | Biotech Hunter

Enrollment

197

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Suppression of Ovulation

Interventions

DRUG

10 µg/day E2 with NES 200® µg/day

10 µg/day E2 with NES 200® µg/day delivered by CVR continuously for 6 months (180 days)

DRUG

20 µg/day E2 with NES 200® µg/day

20 µg/day E2 with NES 200® µg/day delivered by CVR continuously for 6 months (180 days)

DRUG

40 µg/day E2 with NES 200® µg/day

40 µg/day E2 with NES 200® µg/day delivered by CVR continuously for 6 months (180 days)

Trial Locations (8)

NYU School of Medicine, New York

Columbia University, New York

Univeristy of Pittsburgh School of Medicine, Pittsburgh

University of Pennsylvania School of Medicine, Philadelphia

Johns Hopkins School of Medicine, Baltimore

Eastern Virginia Medical School, Norfolk

University of Cincinnati, Cincinnati

Oregon Health & Science University, Portland